BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 18192955)

  • 1. Medical therapy for gastroesophageal reflux disease in 2007.
    Katz PO
    Rev Gastroenterol Disord; 2007; 7(4):193-203. PubMed ID: 18192955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Night acid "bursting": treatment of patients with gastroesophageal reflux disease].
    Vasil'ev IuV; Beliaeva VS
    Eksp Klin Gastroenterol; 2007; (3):83-91. PubMed ID: 17937011
    [No Abstract]   [Full Text] [Related]  

  • 3. Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal reflux.
    Miner PB
    Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():25-32. PubMed ID: 16483267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of symptomatic reflux episodes on Acid suppressive therapy.
    Tutuian R; Vela MF; Hill EG; Mainie I; Agrawal A; Castell DO
    Am J Gastroenterol; 2008 May; 103(5):1090-6. PubMed ID: 18445095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare costs of GERD and acid-related conditions in pediatric patients, with comparison between histamine-2 receptor antagonists and proton pump inhibitors.
    Kothari S; Nelson SP; Wu EQ; Beaulieu N; McHale JM; Dabbous OH
    Curr Med Res Opin; 2009 Nov; 25(11):2703-9. PubMed ID: 19775195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastroesophageal reflux disease (GERD): is there more to the story?
    Vesper BJ; Altman KW; Elseth KM; Haines GK; Pavlova SI; Tao L; Tarjan G; Radosevich JA
    ChemMedChem; 2008 Apr; 3(4):552-9. PubMed ID: 18076011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacological management of gastroesophageal reflux disease.
    Lowe RC; Wolfe MM
    Minerva Gastroenterol Dietol; 2004 Sep; 50(3):227-37. PubMed ID: 15729198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance to H2 receptor antagonist correlates well with the decline in efficacy against gastroesophageal reflux in patients with gastroesophageal reflux disease.
    Furuta K; Adachi K; Komazawa Y; Mihara T; Miki M; Azumi T; Fujisawa T; Katsube T; Kinoshita Y
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1581-5. PubMed ID: 16928220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic laryngitis associated with gastroesophageal reflux: prospective assessment of differences in practice patterns between gastroenterologists and ENT physicians.
    Ahmed TF; Khandwala F; Abelson TI; Hicks DM; Richter JE; Milstein C; Vaezi MF
    Am J Gastroenterol; 2006 Mar; 101(3):470-8. PubMed ID: 16542282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heartburn, gastroesophageal reflux (GER), and gastroesophageal reflux disease (GERD).
    J Pract Nurs; 2008; 58(3):21-3. PubMed ID: 19180847
    [No Abstract]   [Full Text] [Related]  

  • 11. Gastroesophageal reflux disease: pathophysiology and pharmacology overview.
    Dajani EZ
    J Assoc Acad Minor Phys; 2000; 11(1):7-11. PubMed ID: 10826019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
    Miyamoto M; Haruma K; Kuwabara M; Nagano M; Okamoto T; Tanaka M
    J Gastroenterol Hepatol; 2007 May; 22(5):639-44. PubMed ID: 17444849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging drugs for gastroesophageal reflux disease.
    Boeckxstaens GE
    Expert Opin Emerg Drugs; 2009 Sep; 14(3):481-91. PubMed ID: 19650746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of reflux symptoms with over-the-counter proton pump inhibitors: issues and proposed guidelines.
    Haag S; Andrews JM; Katelaris PH; Gapasin J; Galmiche JP; Hunt R; Layer P; Malfertheiner P; Holtmann G
    Digestion; 2009; 80(4):226-34. PubMed ID: 19844107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton pump inhibitor failure--what are the therapeutic options?
    Fass R
    Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S33-8. PubMed ID: 19262545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolving issues in the management of reflux disease?
    Yuan Y; Hunt RH
    Curr Opin Gastroenterol; 2009 Jul; 25(4):342-51. PubMed ID: 19417644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastroesophageal reflux disease.
    Armstrong D
    Curr Opin Pharmacol; 2005 Dec; 5(6):589-95. PubMed ID: 16214410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic approaches to reflux disease, focusing on acid secretion.
    Kinoshita Y; Adachi K; Fujishiro H
    J Gastroenterol; 2003 Mar; 38 Suppl 15():13-9. PubMed ID: 12698865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Barrett esophagus: modern diagnosis, drug therapy and reduce risk of cancer].
    Kashin SV; Ivanikov IO
    Eksp Klin Gastroenterol; 2009; (2):90-8. PubMed ID: 19552026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review: treatment of gastroesophageal reflux disease in the elderly.
    Poh CH; Navarro-Rodriguez T; Fass R
    Am J Med; 2010 Jun; 123(6):496-501. PubMed ID: 20569750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.